Orgotein (superoxide dismutase): A drug for the amelioration of radiation-induced side effects
β Scribed by Menander-Huber, K. B. ;Edsmyr, F. ;Huber, W.
- Publisher
- Springer
- Year
- 1978
- Tongue
- English
- Weight
- 221 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
β¦ Synopsis
Orgotein, the drug version of Cu-Zn superoxide dismutases is a new and safe anti-inflammatory agent. Animal experiments have shown that it does not interfere with the tumourolytic effects of radiation or chemotherapy. A double-blind, placebo-controlled study has demonstrated that orgotein injected after each daily irradiation session can be used safely and effectively to ameliorate or prevent the side effects due to high-energy radiation therapy (8,400 or 6,400 rads) of bladder tumours. Orgotein significantly reduced the signs and symptoms both in the bladder and the bowel, indicating that it provides a therapeutic regimen for control of these side effects, which to date could only be treated symptomatically.
π SIMILAR VOLUMES
Superoxide dismutases (SOD) can be used as anti-oxidization drugs and can eliminate superoxide radicals to protect cells from damage induced by free radicals. However, because of their large molecular weight and impermeability to cell membrane, their drug effectiveness is greatly reduced. Fluorescen
Bystander effects, whereby cells that are not directly exposed to ionizing radiation exhibit adverse biological effects, have been observed in a number of experimental systems. A novel stochastic model of the radiation-induced bystander effect is developed that takes account of spatial location, cel
## Abstract A selfβreport measure of antipsychotic side effects (LUNSERS) was compared with that of an established semiβstructured interview (UKU side effect rating scale). The validity and the ability of the LUNSERS to determine false positives by use of an internal βred herringβ subscale were ass